Peru-15 (Choleragarde®), a live attenuated oral cholera vaccine, is safe and immunogenic in human immunodeficiency virus (HIV)-seropositive adults in Thailand

W. Ratanasuwan,Y.H. Kim,B.K. Sah, S. Suwanagool,D.R. Kim, A. Anekthananon,A.L. Lopez, W. Techasathit, S.L. Grahek,J.D. Clemens,T.F. Wierzba

Vaccine（2015）

引用 7|浏览19

暂无评分

摘要

•Peru-15 demonstrates a satisfactory safety profile in HIV infected Thai adults.•No changes in CD4 T-cell counts and HIV viral load in HIV infected adults were associated with vaccine intake.•The vaccine elicits a fairly high immune response to Vibrio cholerae O1 El Tor in HIV infected adults.

查看译文

关键词

Oral cholera vaccine,Peru-15,Live attenuated cholera vaccine,Immunogenicity,Safety,HIV-seropositive adult

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要